BradRovin United StatesThe Ohio State University

Dr. Brad H. Rovin is the Director of the Division of Nephrology and Vice Chairman of Medicine for Research at the Ohio State University Wexner Medical Center. He is the Lee A. Hebert Distinguished Professor of Nephrology. Dr. Rovin received his Bachelor of Science in Chemical Engineering from Northwestern University in Evanston Illinois and his Doctor of Medicine from the University of Illinois Medical School in Chicago, Illinois. He completed a residency in Internal Medicine at Barnes Hospital in St. Louis Missouri, and a Fellowship in Nephrology at Washington University School of Medicine, St. Louis. Dr. Rovin studies the pathogenesis of glomerular diseases. He has a special interest in lupus nephritis. His research has focused on biomarker development for glomerular diseases. He also studies experimental therapeutics in an effort to find new treatments for glomerular diseases. Dr. Rovin established a multidisciplinary Lupus, Vasculitis and Glomerulonephritis clinic and directs an advanced fellowship in autoimmune diseases for nephrologists and rheumatologists.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/63701af96cbd813ce59a31aaa8e1655f.jpg

First name

Brad

Last name

Rovin

Institution

Country

United States

Friday, February 7, 2025

Time	Session

2:15 p.m. 3:45 p.m.	HIT! High Impact Clinical Trials – What and Why HIT1 Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland VivekKumar Chair IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) HIT1-1 RajivAgarwal Oral Abstract Presenter United States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis HIT1-2 BradRovin Oral Abstract Presenter United StatesThe Ohio State University Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial HIT1-3 KatherineTuttle Oral Abstract Presenter United StatesUniversity of Washington School of Medicine, Division of Nephrology Brahmkamal Hall - Plenary Hall

Time

Session

2:15 p.m.

3:45 p.m.

HIT! High Impact Clinical Trials – What and Why

Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland

VivekKumar Chair IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India

Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)

HIT1-1

RajivAgarwal Oral Abstract Presenter United States
Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

HIT1-2

BradRovin Oral Abstract Presenter United StatesThe Ohio State University
Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial

HIT1-3

KatherineTuttle Oral Abstract Presenter United StatesUniversity of Washington School of Medicine, Division of Nephrology

Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Debunking Nephrology Myths: Insights From Global Kidney Care Leaders BKH2003 SanjayPandya Chair IndiaConsulting Nephrologist, Wockhardt Hospital & Jalaram Hospital, Rajkot SreejithParameswaran Chair IndiaProfessor & Head, Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Revisiting Kidney Biopsies: Why More Than One Can Be Beneficial BKH2003-01 BradRovin Speaker United StatesThe Ohio State University Genetic Testing for Kidney Disease Is Not Complicated BKH2003-02 KelsieBogyo Speaker United StatesColumbia University Irving Medical Center Thrombotic Microangiopathy Workup: Everything You Need to Know BKH2003-03 AnujaJava Speaker United StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS Dealing With Biological Variability in Albuminuria and Creatinine BKH2003-04 SusrutWaikar Speaker United StatesBoston University Chobanian and Avedisian School of Medicine, and Boston Medical Center The Underdiagnosis of Primary Aldosteronism in Clinical Practice BKH2003-05 VivekBhalla Speaker United StatesDirector, Stanford Hypertension Center; Division of Nephrology, Stanford University School of Medicine Q&A BKH2003-06 Brahmkamal Hall - Plenary Hall	The ISN-KI/KIR Editorial Fellows Session: The Best of 2024/25 Articles KI/KIR1 BradRovin Chair United StatesThe Ohio State University GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney PierreRonco Chair pierreronco@yahoo.frFranceHôpital Tenon Kidney International in Focus: Annual Highlights KI/KIR1-01 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon ISN-KI Fellows: Showcasing Excellence Part 1 KI/KIR1-02 Eugene Yu HinChan Speaker Hong Kong, ChinaThe Chinese University of Hong Kong, Hong Kong Children's Hospital ISN-KI Fellows: Showcasing Excellence Part 2 KI/KIR1-03 IsabelleAyoub Speaker United StatesThe Ohio State University ISN-KI Fellows: Showcasing Excellence Part 3 KI/KIR1-04 ChristophKuppe Speaker GermanyDepartment of Nephrology, RWTH University Aachen, Germany ISN-KI Fellows: Showcasing Excellence Part 4 KI/KIR1-05 GriffithPerkins Speaker Australia Q and A Kidney International Reports in Focus: Annual Highlights KI/KIR1-06 JaiRadhakrishnan Speaker United StatesColumbia University in the City of New York Kidney International Reports in Focus: Annual Highlights KI/KIR1-07 SumitMohan Speaker United StatesColumbia University Kidney International Reports in Focus: Annual Highlights KI/KIR1-08 AnnaFrancis Speaker AustraliaUniversity of Queensland Q and A Celebrating Excellence: Best Reviewer Awards Presentation KI/KIR1-09 BradRovin Speaker United StatesThe Ohio State University Recognizing the Best: Basic Science Awards for Early Career Researchers KI/KIR1-10 VeronicaMiguel Speaker SpainSpanish National Centre for Cardiovascular Research Recognizing the Best: Clinical Science Awards for Early Career Researchers KI/KIR1-11 MuzamilHassan Speaker NigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Recognizing the Best: ISN-KI Editorial Fellows Awards KI/KIR1-12 GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney Champa Hall 304
2:15 p.m. 3:45 p.m.	Speed Dating with KI/KIR Editors KI/KIR2 BradRovin Chair United StatesThe Ohio State University GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney PierreRonco Chair pierreronco@yahoo.frFranceHôpital Tenon Introduction KI/KIR2 -1 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon Translational Science/Genomics KI/KIR2-2 ChristophKuppe Speaker GermanyDepartment of Nephrology, RWTH University Aachen, Germany KrzysztofKiryluk Speaker United StatesColumbia University Discovery Science KI/KIR2-3 ReikoInagi Speaker JapanThe University of Tokyo Graduate School of Medicine VeronicaMiguel Speaker SpainSpanish National Centre for Cardiovascular Research Crossing the Lines to ‘Acceptance’ in High Impact Kidney Journals KI/KIR2-5 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon SumitMohan Speaker United StatesColumbia University Epidemiology/Stats/Policy Forum KI/KIR2-6 AnnaFrancis Speaker AustraliaUniversity of Queensland GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney MuzamilHassan Speaker NigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Clinical Trials KI/KIR2-4 BradRovin Speaker United StatesThe Ohio State University Kesar Hall 202